177 related articles for article (PubMed ID: 30808269)
21. Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
Liu K; Zhang Y; Xu X; Wu B; Ni J; Li T; Xing C; Mao H
Clin Ther; 2021 Oct; 43(10):e319-e351. PubMed ID: 34579971
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with acute kidney injury in children receiving vancomycin.
Sinclair EA; Yenokyan G; McMunn A; Fadrowski JJ; Milstone AM; Lee CK
Ann Pharmacother; 2014 Dec; 48(12):1555-62. PubMed ID: 25186624
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
Buckley MS; Komerdelj IA; D'Alessio PA; Rangan P; Agarwal SK; Tinta NC; Martinez BK; Ziadat DS; Yerondopoulos MJ; Kobic E; Kane-Gill SL
J Crit Care; 2022 Feb; 67():134-140. PubMed ID: 34768175
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
Schreier DJ; Kashani KB; Sakhuja A; Mara KC; Tootooni MS; Personett HA; Nelson S; Rule AD; Steckelberg JM; Tande AJ; Barreto EF
Clin Infect Dis; 2019 Apr; 68(9):1456-1462. PubMed ID: 30165426
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with vancomycin nephrotoxicity in the critically ill.
Hanrahan TP; Kotapati C; Roberts MJ; Rowland J; Lipman J; Roberts JA; Udy A
Anaesth Intensive Care; 2015 Sep; 43(5):594-9. PubMed ID: 26310409
[TBL] [Abstract][Full Text] [Related]
26. Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients.
Hodiamont CJ; Juffermans NP; Berends SE; van Vessem DJ; Hakkens N; Mathôt RAA; de Jong MD; van Hest RM
J Antimicrob Chemother; 2021 Oct; 76(11):2941-2949. PubMed ID: 34337660
[TBL] [Abstract][Full Text] [Related]
27. Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use.
Yabes JM; Stewart L; Shaikh F; Robben PM; Petfield JL; Ganesan A; Campbell WR; Tribble DR; Blyth DM
J Intensive Care Med; 2021 Jul; 36(7):818-827. PubMed ID: 32508215
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with acute kidney injury among preterm infants administered vancomycin: a retrospective cohort study.
Shin BS; Shin SH; Park SG; Kim EK; Kim HS
BMC Pediatr; 2023 Jun; 23(1):296. PubMed ID: 37328836
[TBL] [Abstract][Full Text] [Related]
29. Incidence and Risk Factors of Acute Kidney Injury in Patients Receiving Concomitant Vancomycin and Continuous-Infusion Piperacillin/Tazobactam: A Retrospective Cohort Study.
Blair K; Covington EW
Ann Pharmacother; 2020 Nov; 54(11):1096-1101. PubMed ID: 32406243
[TBL] [Abstract][Full Text] [Related]
30. Urinary biomarkers as indicators of acute kidney injury in critically ill children exposed to vancomycin.
Spyhalsky AM; Kim SJ; Meaney CJ; Smith NM; Shah DK; Hassinger AB; Fusco NM
Pharmacotherapy; 2024 Feb; 44(2):163-170. PubMed ID: 37974531
[TBL] [Abstract][Full Text] [Related]
31. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of area under the concentration-time curve-guided vancomycin dosing with or without piperacillin-tazobactam on the incidence of acute kidney injury.
Muklewicz JD; Steuber TD; Edwards JD
Int J Antimicrob Agents; 2021 Jan; 57(1):106234. PubMed ID: 33232734
[TBL] [Abstract][Full Text] [Related]
33. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Gaudard P; Saour M; Morquin D; David H; Eliet J; Villiet M; Daures JP; Colson P
BMC Infect Dis; 2019 May; 19(1):438. PubMed ID: 31109283
[TBL] [Abstract][Full Text] [Related]
34. Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
Carreno J; Smiraglia T; Hunter C; Tobin E; Lomaestro B
Int J Antimicrob Agents; 2018 Nov; 52(5):643-650. PubMed ID: 30103003
[TBL] [Abstract][Full Text] [Related]
35. Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.
Knoderer CA; Gritzman AL; Nichols KR; Wilson AC
Ann Pharmacother; 2015 Oct; 49(10):1113-9. PubMed ID: 26160972
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
Pan K; Ma L; Xiang Q; Li X; Li H; Zhou Y; Yang L; Cui Y
PLoS One; 2017; 12(4):e0175688. PubMed ID: 28426688
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for acute kidney injury in adult patients receiving vancomycin.
Cappelletty D; Jablonski A; Jung R
Clin Drug Investig; 2014 Mar; 34(3):189-93. PubMed ID: 24385282
[TBL] [Abstract][Full Text] [Related]
38. Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit.
Buckley MS; Hartsock NC; Berry AJ; Bikin DS; Richards EC; Yerondopoulos MJ; Kobic E; Wicks LM; Hammond DA
J Crit Care; 2018 Dec; 48():32-38. PubMed ID: 30172962
[TBL] [Abstract][Full Text] [Related]
39. Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity.
Tookhi RF; Kabli NA; Huntul MA; Thabit AK
Intern Emerg Med; 2021 Jun; 16(4):975-979. PubMed ID: 33439417
[TBL] [Abstract][Full Text] [Related]
40. Nephrotoxicity caused by colistin use in ICU: a single centre experience.
Kilic I; Ayar Y; Ceylan İ; Kaya PK; Caliskan G
BMC Nephrol; 2023 Oct; 24(1):302. PubMed ID: 37833622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
